Close Menu

NEW YORK — Curetis said on Thursday that it has signed a deal with Quaphaco to distribute its Unyvero A50 diagnostic system and related application cartridges in Vietnam.

Under the terms of the deal, Ho Chi Minh City-based Quaphaco will exclusively commercialize the Unyvero system and application cartridges for the diagnosis of severe infections in hospitalized patients in Vietnam. The arrangement has an initial three-year term, which can be extended in two-year increments.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

NPR reports the US Food and Drug Administration has approved a treatment for a genetic disorder that causes rapid aging.

Late-stage testing indicates the AstraZeneca and Oxford University SARS-CoV-2 vaccine can have up to 90 percent efficacy, the Associated Press reports.

ScienceInsider reports Nature Communications is reviewing a paper on mentorship following social media criticism arguing it is sexist.

In PLOS this week: method to account for sequencing errors in phylogenies, study of influenza A in Switzerland, and more.

Dec
01
Sponsored by
Roche

Management of viral infections is critical to prevent severe morbidities and consequences in immune-suppressed transplant patients.

Dec
03
Sponsored by
Mission Bio

Recent work by many investigators has discovered that over the course of aging, hematopoietic stem cells (HSCs) commonly undergo clonal expansion.